Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.

Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.